Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Submitted by
admin
on March 20, 2017 - 10:54am
Source:
Investopedia
News Tags:
Pfizer
Merck KGaA
clinical trials
avelumab
non-small cell lung cancer
Headline:
Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome
Do Not Allow Advertisers to Use My Personal information
